The Role of Programmed Necrosis in Colorectal Cancer (2022) Yu Y, Gámez Belmonte MdlR, Patankar J, Liebing E, Becker C Journal article, Review article Early Outcome, Cosmetic Result and Tolerability of an IOERT-Boost Prior to Adjuvant Whole-Breast Irradiation (2022) Jazmati D, Bölke E, Halfmann K, Tamaskovics B, Ruckhäberle E, Fehm T, Hoffmann J, et al. Journal article Predictive Factors of Long-Term Survival after Neoadjuvant Radiotherapy and Chemotherapy in High-Risk Breast Cancer (2022) Haussmann J, Budach W, Nestle-Krämling C, Wollandt S, Tamaskovics B, Corradini S, Bölke E, et al. Journal article EGFR Inhibition Strongly Modulates the Tumour Immune Microenvironment in EGFR-Driven Non-Small-Cell Lung Cancer (2022) Selenz C, Compes A, Nill M, Borchmann S, Odenthal M, Florin A, Braegelmann J, et al. Journal article Integration of p16/HPV DNA Status with a 24-miRNA-Defined Molecular Phenotype Improves Clinically Relevant Stratification of Head and Neck Cancer Patients (2022) Hess J, Unger K, Maihoefer C, Schuettrumpf L, Weber P, Marschner S, Wintergerst L, et al. Journal article Does the Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer Patients Predict the Site of First Metastasis-Results from the Adjuvant SUCCESS A Trial (2022) Trapp EK, Fasching P, Fehm T, Schneeweiss A, Mueller V, Harbeck N, Lorenz R, et al. Journal article Impact of Patient Age on Postoperative Short-Term and Long-Term Outcome after Pancreatic Resection of Pancreatic Ductal Adenocarcinoma (2022) Hackner D, Hobbs M, Merkel S, Siepmann T, Krautz C, Weber G, Grützmann R, Brunner M Journal article The Challenging Management of Craniopharyngiomas in Adults: Time for a Reappraisal? (2022) Cuny T, Buchfelder M, Dufour H, Grossman A, Gatta-Cherifi B, Jouanneau E, Raverot G, et al. Journal article, Review article External Beam Accelerated Partial Breast Irradiation in Early Breast Cancer and the Risk for Radiogenic Pneumonitis (2022) Ott O, Stillkrieg W, Lambrecht U, Sauer TO, Schweizer C, Lamrani A, Strnad V, et al. Journal article Genome-Wide CRISPR Screening Identifies DCK and CCNL1 as Genes That Contribute to Gemcitabine Resistance in Pancreatic Cancer (2022) Yang H, Liu B, Liu D, Yang Z, Zhang S, Xu P, Xing Y, et al. Journal article